Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
4
80%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Active, not recruiting1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (20.0%)
N/A4 (80.0%)

Trials by Status

active_not_recruiting120%
terminated120%
completed120%
unknown240%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingnot_applicable

Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer

NCT03795246
completednot_applicable

Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis

NCT05286684
terminatednot_applicable

Collection of Biological Samples With Clinical Characterization of Covid-19 Patients

NCT04363385
unknownnot_applicable

Neurobiological and Immunological Mechanisms of Dyspnea in ALS (BIOPNEA)

NCT04332198
unknownphase_2

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

NCT02836847

Clinical Trials (5)

Showing 5 of 5 trials
NCT03795246Not Applicable

Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer

Active Not Recruiting
NCT05286684Not Applicable

Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis

Completed
NCT04363385Not Applicable

Collection of Biological Samples With Clinical Characterization of Covid-19 Patients

Terminated
NCT04332198Not Applicable

Neurobiological and Immunological Mechanisms of Dyspnea in ALS (BIOPNEA)

Unknown
NCT02836847Phase 2

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Unknown

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5